|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
SCIDIR_on1304815228 |
| 003 |
OCoLC |
| 005 |
20231120010636.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
220322s2022 enk o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d EBLCP
|d OCLCO
|d OCLCF
|d OCLCQ
|d SFB
|d OCLCQ
|
| 019 |
|
|
|a 1305011308
|a 1305169877
|
| 020 |
|
|
|a 9780128214619
|q (electronic bk.)
|
| 020 |
|
|
|a 0128214619
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128214466
|
| 020 |
|
|
|z 0128214465
|
| 035 |
|
|
|a (OCoLC)1304815228
|z (OCoLC)1305011308
|z (OCoLC)1305169877
|
| 050 |
|
4 |
|a RC685.A65
|
| 082 |
0 |
4 |
|a 616.128
|2 23
|
| 245 |
0 |
0 |
|a Torsades de pointes /
|c [edited by] James E. Tisdale.
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2022.
|
| 300 |
|
|
|a 1 online resource
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro -- Torsades de Pointes -- Copyright -- Dedication -- Contents -- Contributors -- Preface -- Chapter 1: Overview of torsades de pointes -- Introduction -- Definitions and descriptions of TdP -- Defining TdP -- ECG characteristics of TdP -- Historical perspectives -- Evolving understanding on mechanisms of TdP -- Pathophysiology of TdP -- Genesis of TdP -- Perpetuation of TdP -- Spotlight on: Canine models of TdP -- Overview of LQTS and TdP -- Relationship between LQTS and TdP -- Introduction to inherited and acquired QT interval prolongation -- Inherited QT interval prolongation
|
| 505 |
8 |
|
|a Acquired QT interval prolongation -- Interplay of inherited and acquired factors in LQTS -- Epidemiology of TdP -- Overall rates of prolonged QTc interval and TdP -- Inherited LQTS and TdP -- Inherited LQTS -- Inherited TdP -- Acquired LQTS and TdP -- Acquired LQTS -- Acquired TdP -- Consequences of LQTS and TdP -- Symptoms of LQTS and TdP -- Spotlight on: Treatment of inherited LQTS -- Prognosis -- Prognosis in patients with inherited LQTS -- Prognosis in patients with acquired LQTS -- Future directions -- References -- Chapter 2: Torsades de pointes associated with inherited channelopathies
|
| 505 |
8 |
|
|a Introduction -- Long QT syndrome -- Acquired LQTS and the link to congenital LQTS -- Torsades de pointes arrhythmias -- Therapeutic options for torsades de pointes -- Short-coupled torsades de pointes arrhythmia -- Therapeutic options for short-coupled torsades de pointes -- Conclusions -- References -- Chapter 3: Drug-induced torsades de pointes -- Introduction -- Medications as a cause of TdP -- Drug-induced QT interval prolongation and prediction of TdP risk -- Determining causality for drug-induced QT interval prolongation and TdP: The adverse drug event causality analysis (ADECA) ...
|
| 505 |
8 |
|
|a Evidence requirements for risk categories -- Scientific validation of the QTdrugs list and the ADECA process -- Frequency of prescription of QT interval-prolonging medications -- Epidemiology of TdP and death associated with QT interval-prolonging drugs -- Management of risk of drug-induced QT prolongation and TdP -- Conclusion -- References -- Chapter 4: Mechanisms of torsades de pointes -- Introduction -- A brief introduction to ventricular action potential electrogenesis, including INa, IKs, and IKr -- Drugs linked to torsades de pointes in humans and the association with IKr/hERG block
|
| 505 |
8 |
|
|a A role for pharmacological activation of late sodium current in diLQTS -- IKs and repolarization reserve -- Cellular arrhythmogenic events resulting from action potential prolongation: Early afterdepolarizations -- How is torsades de pointes initiated and maintained? -- Insights from genetically altered animal models of LQTS -- Insights into mechanisms of torsades de pointes from models used to study drug-induced long QT syndrome -- Constructing an integrated mechanistic description of torsades de pointes: Is there a final necessary mechanism?
|
| 650 |
|
0 |
|a Arrhythmia.
|
| 650 |
|
0 |
|a Arrhythmia
|x Chemotherapy.
|
| 650 |
|
2 |
|a Arrhythmias, Cardiac
|0 (DNLM)D001145
|
| 650 |
|
6 |
|a Arythmie.
|0 (CaQQLa)201-0019194
|
| 650 |
|
6 |
|a Arythmie
|0 (CaQQLa)201-0019194
|x Chimioth�erapie.
|0 (CaQQLa)201-0379519
|
| 650 |
|
7 |
|a Arrhythmia.
|2 fast
|0 (OCoLC)fst00815084
|
| 650 |
|
7 |
|a Arrhythmia
|x Chemotherapy.
|2 fast
|0 (OCoLC)fst00815085
|
| 700 |
1 |
|
|a Tisdale, James E.,
|e editor.
|
| 776 |
0 |
8 |
|i ebook version :
|z 9780128214619
|
| 776 |
0 |
8 |
|c Original
|z 0128214465
|z 9780128214466
|w (OCoLC)1220993432
|
| 776 |
0 |
8 |
|i Print version:
|t TORSADES DE POINTES.
|d [S.l.] : ELSEVIER ACADEMIC PRESS, 2021
|z 0128214465
|w (OCoLC)1220993432
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128214466
|z Texto completo
|
